Quantel Medical Receives FDA Approval for Next-Generation Compact Touch Ophthalmic Ultrasound Platform

Source: Quantel Medical

Quantel Medical announced that it has received approval from the FDA for the next-generation Compact Touch ophthalmic ultrasound platform.

Improvements in the new generation of Compact Touch include a new 15 MHz B probe to increase the quality of the B-scan imaging essential to vitreo-retinal specialists. Interactivity is enhanced with DICOM compatibility, WiFi, and Bluetooth connectivity and HDMI video output. The sleek, modern design now utilizes a new generation touch screen interface, and the device is fanless and silent as a tablet. User-friendly design and software enhancements improve workflow.

"The new generation 15 MHz B probe of the Compact Touch offers a resolution increased by 30%, which enables me to better differentiate thin vitreous membranes and retinal detachments. It also allows me to visualize tumors inferior to 2mm," Bernard Bievelez, MD, of the Paufique ophthalmologic center, Lyon, France, said in a company news release. "In addition, the system automatically measures the axial length from the B-mode image, which is advantageous when I am evaluating patients who have long myopic eyes, such as patients with staphylomas.”

“We are excited to share with American ophthalmic specialists and their patients the clinical advantages of the new generation of Compact Touch, which enhanced image quality will aid diagnosis,” said Jean?Marc Gendre, CEO of Quantel Medical. “I think physicians also will consider this state-of-the-art technology very practical because these capabilities come in a sleek, portable, well- designed and highly interactive package.”

At the upcoming ASCRS Congress, to be held in Washington DC on April 13-17, the attendees will be able to view the new Compact Touch ultrasound platform with its new B-mode probe and get additional information in exhibit booth #850.


Related Content